New research indicates that individuals who come off blockbuster weight-loss injections like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who halt conventional diet and exercise regimens.
Findings released in a leading medical journal demonstrates that while overweight people often shed a large proportion of their body weight while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month once they quit.
"Individuals buying such medications must be aware of the danger of rapid rebound weight gain when the medication is stopped," stated researcher Dr. Susan Jebb.
That rate of regain suggests a return to starting mass in about a year and a half.
Comparing Treatments
The research, which examined dozens of trials involving thousands of participants, compared the results of the injectable medications with older methods.
The team note that individuals who shed pounds through lifestyle changes alone usually see a slower weight regain—perhaps 100 grams monthly—after stopping.
Explaining the Quick Regain
Doctors believe the mechanism of the jabs is key to understanding the heightened rebound.
These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of the hormone levels several times higher than normal may cause the system to generate a reduced amount of its own natural GLP-1, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication results in hunger is uncontrolled, making binge eating far more likely."
A Chronic Disease?
Health authorities recommend the injections for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.
Many experts contend that, given the high risk of weight regain, the therapy is often ongoing.
This opinion is reinforced by pharmaceutical companies, who note that the findings "underscore the long-term nature of obesity," akin to managing conditions like diabetes.
User Experiences
Users who have come off the jabs explain a intense resurgence of cravings.
"It felt as if a trigger that goes on and you become extremely hungry," recalled an individual.
This difficulty is worsened if individuals have not adopted permanent lifestyle or habit modifications during therapy.
Growing Interest
Survey data show that a significant number of adults in the UK have used these injections in the last 12 months, with interest remaining high.
- Adoption is greater among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
Ultimately, researchers emphasize that while GLP-1 drugs are effective tools for weight loss, they are not a standalone solution and maintained weight loss relies on combined lifestyle changes.
